Nevolat

Nevolat is the generic version of Saxenda, meaning both contain the same active ingredient (liraglutide). Nevolat is manufactured by Zentiva, whereas Saxenda is produced by Novo Nordisk. The key difference between these two products is cost: Nevolat is available at a lower price point than Saxenda. Therefore, Nevolat is the best choice for those seeking a more cost-effective liraglutide injection.

Nevolat may not be safe for people with certain health conditions, and is not recommended for those with

• Congestive heart failure

• Inflammatory bowel disease

• Diabetic gastroparesis

• Acute pancreatitis

   

Doctors also exercise caution when prescribing Nevolat to people over the age of 75 and to those with kidney and liver problems. This is due to a lack of information on the effects of liraglutide in these populations, so their risk of adverse events is unknown.

Talk to your doctor about any pre-existing medical conditions before you take liraglutide. If you experience severe or persistent side effects from this medication, seek the advice of a healthcare professional.

Doctors recommend that people on Nevolat avoid or limit their alcohol intake, as this can increase their risk of hypoglycemia (very low blood sugar). Alcohol consumption may also worsen other side effects like nausea, vomiting, and diarrhoea. Research suggests that liraglutide treatment may reduce alcohol cravings and consumption, making it easier to limit your intake. 

If you have any questions about safe alcohol consumption on Nevolat or any other type of weight loss injection, discuss these with your prescribing clinician before you begin treatment.

There are several important steps you should take when using the Nevolat injection pen. These include:

• Remove the pen cap and examine the solution through the window

• Take off the paper tab from the needle and attach it securely

• Remove the outer needle cap (you’ll need it later) and throw away the inner needle cap

• Turn the dose selector to the ‘flow check’ symbol and hold the pen with the needle pointing upwards

• Press and hold the dose button until the counter returns to 0

• Once the flow has been checked, turn the dose selector until it shows the correct dosage

• Insert the needle into the injection side, pressing and holding the dose button until the counter shows 0

• Continue holding the dose button and slowly count to 6

• Remove the needle and release the dosage button

• Put the needle tip into the outer cap

• Unscrew the needle and dispose of it carefully  

How long a Nevolat pen lasts depends on where you are in the titration schedule. Each injection pen holds 18 mg of liraglutide, and you will continue using the same one until the solution is fully used or there is not enough left to cover the next dose. 

The table below outlines how long a Nevolat pen should last:

 

Assuming you’re following the recommended Nevolat dosage schedule, each injection pen should last for 6 days once you’ve reached the maximum maintenance dose of 3 mg. As a result, you will need 5 pens to last for 30 days.

Nevolat injections should be stored out of the sight and reach of children and animals. Before opening, keep it in a refrigerator between 2˚C-8˚C and away from the freezer compartment. Once you start using the pen, it can stay in the fridge or be kept at a temperature below 30˚C for one month. Do not use after the expiry date. 

When you are not using the pen, it’s important to keep the pen cap to protect it from harsh light. Take care not to use the pen if the solution is not clear and colourless. More information can be found within the Patient Information Leaflet

Yes, you can switch to Nevolat pens from other weight loss treatments. This is true for both tablets and injections. If you’d like to change medications, you must first consult a specialist clinician who will examine your reasons for switching and determine whether liraglutide is a suitable option for you.

There are several alternatives to Nevolat injections to help you lose weight. Each has its own mechanism of action and set of characteristics, so it’s important to determine whether your chosen medication is right for you. A clinician will help you do this. 

At Weight Loss Journey, we offer the following treatments:

• Mounjaro: Regarded as one of the most effective weight loss injections, Mounjaro contains the dual-action ingredient tirzepatide. The treatment could result in a 20.9% drop in body weight after 36 weeks. 

• Wegovy: A once-weekly subcutaneous injection, Wegovy’s active ingredient, semaglutide, may help you lose at least 15% of your starting body weight. 

• Mysimba: These tablets contain active ingredients that were initially used to treat addiction. Mysimba users could see a 3.67kg drop in body weight. 

• Xenical: Containing the active ingredient orlistat, Xenical tablets have been proven to help people lose 2.89kg more than a placebo. 

• Orlistat: The generic and more cost-effective version of Xenical. Orlistat helps weight loss by blocking the absorption of 30% of the fat you eat, thereby facilitating a calorie deficit. 

• Alli: An over-the-counter version of Orlistat and Xenical that contains just 60 mg of the active ingredient. Alli could result in at least a 10% weight loss after 6 months.